Ocular Inflammation Treatment Market is Projected to Reach Valuation of US$ 530 Million by 2026

1
Ocular Inflammation Treatment Market

• Ocular Inflammation Treatment Market Segmentation
  by Treatment Type - Corticosteroids, Antibiotics,
  Monoclonal Antibodies, Immunosuppressant,
  Cycloplegic Agents, Antivirals Disease Type -
  Anterior Uveitis, Posterior Uveitis, Panuveitis,
  Intermediate Uveitis Mode of Administration -
  Topical, Injectables, Oral, and Others
  Distribution Channel - Hospital Pharmacies,
  Retail Pharmacies, Online Pharmacies, and Drug
  Stores, and Forecast 2017-2026

2019 Transparency Market Research, All Rights
Reserved
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Market Overview
Chapter 4 Market Dynamics
Chapter 5 Global Ocular Inflammation Treatment Market Analysis and Forecasts, By Software Type
Chapter 6 Global Ocular Inflammation Treatment Market Analysis, by Modality
Chapter 7 Global Ocular Inflammation Treatment Market Analysis, by Application
Chapter 8 Global Ocular Inflammation Treatment Market Analysis, by End-user
Chapter 9 Global Ocular Inflammation Treatment Market Analysis and Forecast by Region
Chapter 10 Europe Ocular Inflammation Treatment Market Analysis and Forecast
Chapter 11 Asia Pacific Ocular Inflammation Treatment Market Analysis and Forecast
Chapter 12 Latin America Ocular Inflammation Treatment Market Analysis and Forecast
Chapter 13 Middle East Africa Ocular Inflammation Treatment Market Analysis and Forecast
Chapter 14 Competition Landscape

2019 Transparency Market Research, All Rights
Reserved
3
Ocular Inflammation Treatment Market - Snapshot

• Eye inflammations or uveitis are becoming a
  common problem for people across global
  geographies.
• New drugs are being discovered to treat ocular
  inflammations, and companies are investing
  millions for their approval through regulatory
  pipelines.
• Patients are exhibiting a particular preference
  to the type of ocular inflammation treatment
  being adopted, considering the range of treatment
  options, their comparative effectiveness, and
  convenience in terms of mode of administration.
• The global market for ocular inflammation
  treatment is expected to grow sharply in the
  coming years.

2019 Transparency Market Research, All Rights
Reserved
4
(No Transcript)
5
Reports Highlights

• Key projections from the study assess the global
  ocular inflammation treatment market to touch a
  US 1 billion value by the end of 2026.
• Increasing contamination of environment by
  emission of toxins has elevated the risks of
  ocular inflammation, also known as uveitis.
• Evolving medical technologies and drug discovery
  developments have paved way for effective
  treatment of ocular inflammation.
• Prominent market players are diversifying their
  product lines to cater treatment of all forms of
  uveitis occurring worldwide.

2019 Transparency Market Research, All Rights
Reserved
6
Continue..

• Regulatory stance of the FDA towards clearing
  uveitis drugs from the pipelines is improving,
  and market players are being favored to introduce
  novel administration techniques for ocular
  inflammation treatments.
• During the period of assessment, 2017-2026, the
  global market for ocular inflammation treatments
  is pegged to expand at a CAGR of 6.9 in terms of
  value.
• In addition to Allergan, TMR also observes high
  stakes of Novartis AG, Valeant Pharmaceuticals
  International, Inc., Abbvie, Inc., Alimera
  Sciences, Inc., Eyegate Pharmaceuticals, Inc.,
  pSivida Corp., Pfizer, Inc., Cipla Ltd., and
  Akorn, Inc. in the global ocular inflammation
  treatment market over the coming years.

2019 Transparency Market Research, All Rights
Reserved
7
Contact

• To know more about us, please visit our website
• www.transparencymarketresearch.com
• For sales queries or new topics email us on
• sales_at_transparencymarketresearch.com
• Thank You

2019 Transparency Market Research, All Rights
Reserved